AMLX
Price
$14.95
Change
-$0.22 (-1.45%)
Updated
Oct 17 closing price
Capitalization
1.59B
19 days until earnings call
Intraday Buy/Sell Signals
RGNX
Price
$11.73
Change
-$0.61 (-4.94%)
Updated
Oct 17 closing price
Capitalization
592.53M
18 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

AMLX vs RGNX

Header iconAMLX vs RGNX Comparison
Open Charts AMLX vs RGNXBanner chart's image
Amylyx Pharmaceuticals
Price$14.95
Change-$0.22 (-1.45%)
Volume$1.88M
Capitalization1.59B
REGENXBIO
Price$11.73
Change-$0.61 (-4.94%)
Volume$392.97K
Capitalization592.53M
AMLX vs RGNX Comparison Chart in %
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. RGNX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (AMLX: $14.95 vs. RGNX: $11.73)
Brand notoriety: AMLX and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 101% vs. RGNX: 66%
Market capitalization -- AMLX: $1.59B vs. RGNX: $592.53M
AMLX [@Biotechnology] is valued at $1.59B. RGNX’s [@Biotechnology] market capitalization is $592.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 5 bearish.
  • RGNX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +4.84% price change this week, while RGNX (@Biotechnology) price change was +7.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.6B) has a higher market cap than RGNX($593M). AMLX YTD gains are higher at: 295.503 vs. RGNX (51.746). RGNX has higher annual earnings (EBITDA): -129.93M vs. AMLX (-196.3M). RGNX has more cash in the bank: 323M vs. AMLX (181M). AMLX has less debt than RGNX: AMLX (5.96M) vs RGNX (77.7M). RGNX has higher revenues than AMLX: RGNX (156M) vs AMLX (-249K).
AMLXRGNXAMLX / RGNX
Capitalization1.6B593M269%
EBITDA-196.3M-129.93M151%
Gain YTD295.50351.746571%
P/E Ratio2.69N/A-
Revenue-249K156M-0%
Total Cash181M323M56%
Total Debt5.96M77.7M8%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXRGNX
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLSX89.77N/A
N/A
Rydex Leisure A
TRLIX24.55N/A
N/A
Nuveen Large Cap Value R6
IUEFX30.31N/A
N/A
JPMorgan International Focus R5
MSAAX20.80N/A
N/A
Morgan Stanley Inst Passport ovrs eq C
OCMPX17.89N/A
N/A
Lazard International Quality Gr Open

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-1.45%
XOMAO - AMLX
68%
Closely correlated
-0.04%
XOMAP - AMLX
51%
Loosely correlated
+0.10%
OCUL - AMLX
46%
Loosely correlated
-2.95%
RGNX - AMLX
44%
Loosely correlated
-4.94%
JAZZ - AMLX
43%
Loosely correlated
+1.35%
More